Replies to post #19887 on Intellect Neurosciences Inc. (fka ILNS)

[mkaiz]

Maza already knew ponezumab wasn't going to b cure or treatment , and he more focused on , ox1 and tau c 3 better chance for success , ponezumab is part of study from original study of clear plaques , then after that failed they are now more focused on tau protein pone is old news , tau c 3, ox1 and and are new focus we moved past pone a while ago that's what new investors are giving money for